This is a non-core endpoint: only basic statistics are computed.
Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge
VWXY20_MURDER_HOMIC_OTHER_ASSAU_RIFLE_SHOTG_LARGER_FIREA_DISCH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
31 |
4. Check minimum number of eventsNone |
31 |
5. Include endpointsNone |
31 |
6. Filter based on genotype QC (FinnGen only) |
31 |
Control definitions (FinnGen only)
- Control exclude
- VWXY20_ASSAULT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X85-Y09
Similar endpoints
↥List of similar endpoints to
Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge
based on the number of shared cases.
Similar with more cases:
- Assault
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 31 | 10 | 21 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 43.48 | 40.08 | 45.10 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
6
11.96
3.66
1.7
11.0
g/l
126.7
123.5
—
6
6
(3000991) Gas panel - Venous blood
8
14
7.27
3.61
12.8
12.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
8
15
6.77
3.45
18.0
10.7
mmol/l
103.9
103.8
—
8
15
(3028707) Methadone [Presence] in Urine by Screen method
5
6
9.61
2.85
2.2
2.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
20
5.00
2.79
4.3
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
14
59
3.50
2.79
31.6
9.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
10
5.72
2.15
14.4
10.6
%
1.5
1.4
—
5
10
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
10
5.72
2.15
14.4
10.6
%
0.9
0.6
—
5
10
(3042936) Bacteria identified in Isolate by Culture
8
28
3.48
2.03
8.4
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
11
5.18
2.02
2.2
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
6
17
4.11
1.94
35.0
17.1
mmol/l
8.0
8.8
—
6
17
(21494755) Public health laboratory ask at order entry panel
0
47
0.00
1.90
0.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
46
0.00
1.90
0.0
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
18
246
0.36
1.88
5.6
4.1
mmol/l
2.6
2.9
0.63
18
232
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
18
3.87
1.85
2.0
2.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
25
292
0.26
1.85
73.2
19.4
e9/l
7.3
6.6
0.90
25
284
(3026361) Erythrocytes [#/volume] in Blood
25
292
0.26
1.85
73.2
19.2
e12/l
4.4
4.7
1.43
25
284
(3044640) Blood type and Crossmatch panel - Blood
14
73
2.67
1.80
8.4
2.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
11
51
2.79
1.76
23.8
4.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
19
3.65
1.76
2.2
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
19
3.65
1.76
2.2
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
19
3.65
1.76
2.2
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
19
3.65
1.76
2.2
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
25
291
0.27
1.76
73.3
19.3
e9/l
253.2
251.0
0.06
25
283
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
17
100
2.55
1.70
5.9
4.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
14
4.04
1.68
17.8
9.1
mmol/l
25.4
24.7
—
5
14
(3022145) Colonoscopy Study observation
6
20
3.46
1.67
2.0
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
9
41
2.67
1.53
9.4
2.3
mosm/kgh2o
555.6
589.8
—
9
34
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
17
106
2.34
1.43
29.5
10.0
mmol/l
1.2
1.2
0.75
17
88
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
11
58
2.39
1.32
6.2
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
19
2.93
1.26
2.0
1.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
6
26
2.61
1.25
3.0
1.4
g/l
8.8
9.7
—
6
20
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5
22
2.51
1.07
1.6
3.3
mmol/l
2.4
2.5
—
5
17
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
15
98
2.03
1.04
23.7
8.0
mmol/l
1.2
1.2
0.66
15
89
(3024561) Albumin [Mass/volume] in Serum or Plasma
13
81
2.04
1.02
23.5
6.0
g/l
35.6
36.8
0.22
13
75
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
23
269
0.44
0.99
36.9
9.9
u/l
28.4
30.0
0.11
23
264
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
8
45
2.04
0.93
3.6
1.6
%
1.8
1.3
—
8
39
(3013826) Glucose [Moles/volume] in Serum or Plasma
19
141
1.90
0.87
8.2
4.1
mmol/l
6.0
6.5
1.13
19
132
(3017143) Hepatitis C virus Ab [Presence] in Serum
9
54
1.94
0.85
1.9
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
10
61
1.94
0.80
4.2
5.0
mmol/l
2.3
2.3
—
10
52
(3021960) Folate [Moles/volume] in Serum or Plasma
7
40
1.96
0.78
1.4
1.4
nmol/l
18.0
19.9
—
7
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
79
1.85
0.77
1.8
2.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
7
41
1.91
0.76
11.9
2.4
e6/l
5.3
3.7
—
7
36
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
11
73
1.79
0.68
11.1
3.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
19
0.00
0.62
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
21
0.00
0.62
0.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
9
61
1.67
0.61
11.8
2.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
25
273
0.57
0.60
48.2
13.2
umol/l
85.0
80.4
0.19
25
273
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9
63
1.60
0.59
1.4
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
15
113
1.63
0.58
35.3
8.1
%
0.5
0.7
0.45
15
108
(3037467) Urinalysis macro (dipstick) panel - Urine
12
158
0.61
0.58
12.0
4.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
6
39
1.66
0.57
8.2
2.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
6
39
1.66
0.57
5.2
1.7
ug/g
152.5
73.0
—
6
31
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
18
215
0.61
0.56
3.2
3.6
mu/l
1.5
1.8
1.31
18
204
(40761511) CBC panel - Blood by Automated count
24
263
0.61
0.52
39.7
11.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
16
126
1.56
0.49
33.9
7.7
%
31.0
29.5
0.23
16
120
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
18
0.00
0.41
0.0
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
18
0.00
0.41
0.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
6
86
0.63
0.40
2.8
2.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
6
41
1.57
0.39
2.0
1.7
—
551.4
—
0
14
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
62
1.39
0.32
2.1
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
11
89
1.37
0.25
30.9
6.9
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
5
38
1.38
0.25
15.2
2.6
s
28.5
29.0
—
5
38
(3003740) Influenza virus B Ag [Presence] in Specimen
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
11
0.00
0.22
0.0
2.5
—
0.0
—
0
11
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
11
0.00
0.22
0.0
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.5
—
1.1
—
0
10
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.5
—
0.2
—
0
10
(3023420) DNA double strand Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
50
1.25
0.21
1.7
2.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
6.2
—
0
13
(40768443) Skin Pathology biopsy report
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
7
56
1.32
0.20
3.6
3.7
mg/l
69.5
130.8
—
7
38
(3020682) Albumin/Creatinine [Ratio] in Urine
7
58
1.27
0.20
4.0
4.3
mg/mmol
16.0
17.6
—
7
43
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
7
60
1.21
0.19
1.9
1.7
mmol/l
1.6
1.6
—
7
53
(3003694) ABO and Rh group [Type] in Blood
6
74
0.77
0.18
1.7
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
77
1.24
0.18
8.3
3.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
17
187
0.80
0.16
38.8
8.0
u/l
91.8
73.4
0.67
17
176
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
19
204
0.82
0.12
4.1
3.7
—
—
—
0
0
(3044889) 12 lead EKG panel
15
163
0.85
0.10
3.8
3.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
5
60
0.80
0.09
17.0
4.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
5
59
0.82
0.09
4.8
3.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
9
84
1.10
0.08
2.6
1.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
14
133
1.10
0.02
9.5
3.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
10
98
1.03
0.00
7.4
2.9
ug/l
345.5
136.2
—
10
88
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
25
247
1.06
0.00
54.3
13.5
mmol/l
4.0
4.0
0.18
25
242
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
58
1.04
0.00
11.3
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013512) EKG study
5
55
0.89
0.00
4.4
3.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015736) pH of Urine
9
90
1.00
0.00
3.3
2.9
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
9
91
0.98
0.00
7.8
2.3
nmol/l
71.6
70.1
—
9
83
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
8
0.00
0.00
0.0
1.0
—
1.1
—
0
8
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
11.1
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_MURDER_HOMIC_OTHER_ASSAU_RIFLE_SHOTG_LARGER_FIREA_DISCH – Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).